[시장보고서]고분자 바이오 분석 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 및 서비스별(제품, 서비스), 용도별, 지역별, 경쟁별(2020-2030년)

고분자 바이오 분석 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 및 서비스별(제품, 서비스), 용도별, 지역별, 경쟁별(2020-2030년)

Large Molecule Bioanalytical Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products & Services (Product, Service), By Application, By Region and Competition, 2020-2030F

상품코드 : 1714251

리서치사 : TechSci Research

발행일 : 2025년 04월

페이지 정보 : 영문 184 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,485,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,927,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,530,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

고분자 바이오 분석 기술 세계 시장 규모는 2024년 95억 4,000만 달러, 2030년에는 172억 1,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 CAGR은 10.31%로 견조한 성장을 기록할 것으로 예상됩니다.

시장 성장의 원동력은 생물학적 제제 및 바이오시밀러 파이프라인의 확대와 만성질환 및 생명을 위협하는 질환의 치료에서 저분자 의약품보다 생물학적 제제가 선호되고 있다는 점입니다. 이러한 첨단 치료제는 의약품 개발의 모든 단계에서 정확한 특성화, 정량화, 검증을 위한 정밀한 분석 도구가 필요합니다. 단클론항체, 재조합 단백질, 유전자 치료제의 사용이 증가함에 따라 제약회사와 연구기관은 고처리량, 고감도 기술에 대한 투자를 늘리고 있습니다. 하이브리드 분석 플랫폼, 디지털 자동화, AI 통합과 같은 새로운 트렌드는 바이오 분석 워크플로우를 더욱 변화시키고 있습니다. 이 분야는 기술 발전의 혜택을 누리는 한편, 고가의 설비 투자 및 엄격한 규제 기준과 관련된 도전에 직면하고 있습니다. 생물학적 제제의 복잡성으로 인해 분석 방법의 지속적인 혁신과 표준화가 필요하며, 바이오 제약 산업에서 첨단 바이오 분석 기술의 중요한 역할이 강화되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	95억 4,000만 달러
시장 규모 : 2030년	172억 1,000만 달러
CAGR : 2025-2030년	10.31%
급성장 부문	세포-유전자 치료
최대 시장	북미

시장 촉진요인

생물학적 제제 및 바이오시밀러 수요 확대

주요 시장 과제

고급 분석 장비의 높은 비용

주요 시장 동향

하이브리드 분석 기술 채택

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 제품 및 서비스별(제품(소모품·부속품, 기기, 시약·키트), 서비스)
- 용도별(생물학적 제제, 올리고뉴클레오티드 유래 의약품·분자, 바이러스 벡터, 세포 및 유전자 치료, 나노입자·폴리머, 기타)
- 기업별(2024년)
- 지역별
시장 맵

제6장 북미의 고분자 바이오 분석 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 멕시코
- 캐나다

제7장 유럽의 고분자 바이오 분석 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 프랑스
- 독일
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 고분자 바이오 분석 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 한국
- 일본
- 호주

제9장 남미의 고분자 바이오 분석 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 고분자 바이오 분석 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제14장 경쟁 구도

Intertek Group plc
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc.
Solvias
Bio-Techne
Waters Corporation
Verder Scientific GmbH & Co. KG
Charles River Laboratories
Merck KGaA
Cergentis B.V.

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm

영문 목차

영문목차

The global market for large molecule bioanalytical technologies was valued at USD 9.54 billion in 2024 and is projected to reach USD 17.21 billion by 2030, registering a robust CAGR of 10.31% during the forecast period. Market growth is being fueled by the expanding pipeline of biologics and biosimilars, along with the increasing preference for biologic therapies over small molecules in treating chronic and life-threatening conditions. These advanced therapeutics require precise analytical tools for accurate characterization, quantification, and validation across all phases of drug development. The rise in the use of monoclonal antibodies, recombinant proteins, and gene therapies is prompting pharmaceutical companies and research organizations to invest in high-throughput, sensitive technologies. Emerging trends such as hybrid analytical platforms, digital automation, and AI integration are further transforming bioanalytical workflows. While the sector benefits from technological progress, it continues to face challenges related to high capital investment and stringent regulatory standards. The complexity of biologics also necessitates ongoing innovation and standardization in analytical methodologies, reinforcing the critical role of advanced bioanalytical technologies in the biopharmaceutical industry.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 9.54 Billion
Market Size 2030	USD 17.21 Billion
CAGR 2025-2030	10.31%
Fastest Growing Segment	Cell & Gene Therapy
Largest Market	North America

Key Market Drivers

Growing Demand for Biologics and Biosimilars

The global shift toward biologics and biosimilars as preferred therapeutic modalities is a key driver of demand for large molecule bioanalytical technologies. Biologics, including monoclonal antibodies and therapeutic proteins, offer high specificity and efficacy in treating complex conditions such as cancer and autoimmune diseases. As these therapies require extensive analytical testing throughout their development and regulatory lifecycle, the need for reliable, high-precision bioanalytical platforms has grown significantly. Additionally, regulatory mandates for biosimilar comparability studies further intensify the demand for advanced analytical solutions to evaluate safety, efficacy, and quality. The increasing adoption of biologics across diverse therapeutic areas ensures a sustained need for robust, sensitive, and scalable bioanalytical technologies.

Key Market Challenges

High Costs of Advanced Analytical Instruments

The adoption of large molecule bioanalytical technologies is often hindered by the high costs associated with procuring and operating advanced instruments. Technologies such as LC-MS/MS and surface plasmon resonance systems require substantial capital investment and ongoing operational expenses. These costs include maintenance, calibration, consumables, and software licensing. For small and mid-sized laboratories or emerging biotech firms, such financial demands can be a major constraint. This challenge is compounded by the need for highly skilled personnel to operate and maintain these systems, limiting market penetration in resource-constrained settings.

Key Market Trends

Adoption of Hybrid Analytical Techniques

An emerging trend in the market is the increased use of hybrid analytical methods, particularly those that integrate ligand-binding assays with LC-MS/MS. This combination enhances both sensitivity and specificity, making it ideal for analyzing complex biologics such as monoclonal antibodies and fusion proteins. These techniques are especially useful in pharmacokinetics, pharmacodynamics, and immunogenicity studies, where the detection of trace levels of analytes in complex biological samples is critical. Regulatory bodies are acknowledging the value of these integrated approaches, further promoting their adoption in both early-stage research and clinical development.

Key Market Players

Intertek Group plc
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc.
Solvias
Bio-Techne
Waters Corporation
Verder Scientific GmbH & Co. KG
Charles River Laboratories
Merck KGaA
Cergentis B.V.

Report Scope:

In this report, the Global Large Molecule Bioanalytical Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Large Molecule Bioanalytical Technologies Market, By Products & Services:

Product

Consumables & Accessories

Instruments

Reagents & Kits

Service

Large Molecule Bioanalytical Technologies Market, By Application:

Biologics
Oligonucleotide Derived Drugs & Molecules
Viral Vector
Cell & Gene Therapy
Nanoparticles & Polymers
Others

Large Molecule Bioanalytical Technologies Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Large Molecule Bioanalytical Technologies Market.

Available Customizations:

Global Large Molecule Bioanalytical Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Large Molecule Bioanalytical Technologies Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Products & Services (Product (Consumables & Accessories, Instruments, Reagents & Kits), Service)
- 5.2.2. By Application (Biologics, Oligonucleotide Derived Drugs & Molecules, Viral Vector, Cell & Gene Therapy, Nanoparticles & Polymers, Others)
- 5.2.3. By Company (2024)
- 5.2.4. By Region
5.3. Market Map

6. North America Large Molecule Bioanalytical Technologies Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Products & Services
- 6.2.2. By Application
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Large Molecule Bioanalytical Technologies Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Products & Services
    - 6.3.1.2.2. By Application
- 6.3.2. Mexico Large Molecule Bioanalytical Technologies Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Products & Services
    - 6.3.2.2.2. By Application
- 6.3.3. Canada Large Molecule Bioanalytical Technologies Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Products & Services
    - 6.3.3.2.2. By Application

7. Europe Large Molecule Bioanalytical Technologies Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Products & Services
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Large Molecule Bioanalytical Technologies Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Products & Services
    - 7.3.1.2.2. By Application
- 7.3.2. Germany Large Molecule Bioanalytical Technologies Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Products & Services
    - 7.3.2.2.2. By Application
- 7.3.3. United Kingdom Large Molecule Bioanalytical Technologies Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Products & Services
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Large Molecule Bioanalytical Technologies Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Products & Services
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Large Molecule Bioanalytical Technologies Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Products & Services
    - 7.3.5.2.2. By Application

8. Asia-Pacific Large Molecule Bioanalytical Technologies Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Products & Services
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Large Molecule Bioanalytical Technologies Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Products & Services
    - 8.3.1.2.2. By Application
- 8.3.2. India Large Molecule Bioanalytical Technologies Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Products & Services
    - 8.3.2.2.2. By Application
- 8.3.3. South Korea Large Molecule Bioanalytical Technologies Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Products & Services
    - 8.3.3.2.2. By Application
- 8.3.4. Japan Large Molecule Bioanalytical Technologies Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Products & Services
    - 8.3.4.2.2. By Application
- 8.3.5. Australia Large Molecule Bioanalytical Technologies Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Products & Services
    - 8.3.5.2.2. By Application

9. South America Large Molecule Bioanalytical Technologies Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Products & Services
- 9.2.2. By Application
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Large Molecule Bioanalytical Technologies Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Products & Services
    - 9.3.1.2.2. By Application
- 9.3.2. Argentina Large Molecule Bioanalytical Technologies Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Products & Services
    - 9.3.2.2.2. By Application
- 9.3.3. Colombia Large Molecule Bioanalytical Technologies Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Products & Services
    - 9.3.3.2.2. By Application

10. Middle East and Africa Large Molecule Bioanalytical Technologies Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Products & Services
- 10.2.2. By Application
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Large Molecule Bioanalytical Technologies Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Products & Services
    - 10.3.1.2.2. By Application
- 10.3.2. Saudi Arabia Large Molecule Bioanalytical Technologies Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Products & Services
    - 10.3.2.2.2. By Application
- 10.3.3. UAE Large Molecule Bioanalytical Technologies Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Products & Services
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Intertek Group plc
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. F. Hoffmann-La Roche Ltd
14.3. Bio-Rad Laboratories, Inc.
14.4. Solvias
14.5. Bio-Techne
14.6. Waters Corporation
14.7. Verder Scientific GmbH & Co. KG
14.8. Charles River Laboratories
14.9. Merck KGaA
14.10. Cergentis B.V.